文献速递重症综合管理与镇静镇痛心脑血管急症

血管生成素-2与毛细血管渗漏相关并预测心脏手术后并发症

Angiopoietin-2 is associated with capillary leak and predicts complications after cardiac surgery.
PubMed 文献 · Ann Intensive Care · 2023-08-08
一句话结论心脏手术后血管生成素-2升高与细胞外水增加相关,并增加急性肾损伤等术后并发症风险,联合细胞外水可能有助于预测术后并发症。

这项前瞻性观察性多学科队列研究在三级学术医疗中心纳入405例心脏手术患者,术后每日用生物电阻抗分析、超声、舌下活体显微镜和血清生物标志物评估。术后细胞外水从术前20±6L增至术后第2天29±7L(P<0.001),血管生成素-2随之升高,与细胞外水强相关(r=0.959,P=0.041)。控制水肿常见危险因素后,血管生成素-2每增加1 ng/mL与细胞外水增加0.24L相关(P<0.001),并增加急性肾损伤风险(OR 1.095 [95% CI 1.032, 1.169];P=0.004),还与延迟拔管、ICU时间延长和血管活性药物依赖时间延长相关。作者认为血管生成素-2联合细胞外水在预测心脏手术后并发症方面有前景。

要点

  • 心脏手术后细胞外水从术前20±6L增至术后第2天29±7L(P<0.001),血管生成素-2随之升高,与细胞外水强相关(r=0.959,P=0.041)。
  • 控制水肿常见危险因素后,血管生成素-2每增加1 ng/mL与细胞外水增加0.24L相关(P<0.001)。
  • 血管生成素-2升高增加急性肾损伤风险(OR 1.095 [95% CI 1.032, 1.169];P=0.004)。
  • 血管生成素-2还与延迟拔管、ICU时间延长和血管活性药物依赖时间延长相关。
  • 将毛细血管渗漏加入标准危险因素后,机器学习可预测术后并发症。

适用人群与场景

  • 接受心脏手术的患者,多数行冠状动脉旁路移植术、瓣膜手术或主动脉手术。

研究设计与关键结果

  • 研究类型为前瞻性观察性多学科队列研究,在三级学术医疗中心纳入405例心脏手术患者。
  • 术后细胞外水从术前20±6L增至术后第2天29±7L(P<0.001)。
  • 血管生成素-2水平随细胞外水升高而升高,基于测量时间点显示强相关(r=0.959,P=0.041)。
  • 提示毛细血管渗漏的炎症标志物(IL-6、IL-8、CRP)和内皮标志物(VE-Cadherin、syndecan-1、ICAM-1)升高。
  • 控制水肿常见危险因素后,血管生成素-2每增加1 ng/mL与细胞外水增加0.24L相关(P<0.001)。
  • 血管生成素-2增加急性肾损伤风险(OR 1.095 [95% CI 1.032, 1.169];P=0.004)。
  • 血管生成素-2还与延迟拔管、ICU时间延长和血管活性药物依赖时间延长相关。
  • 将毛细血管渗漏加入标准危险因素后,机器学习可预测术后并发症。

证据类型、等级与局限

  • 证据类型:前瞻性观察性多学科队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,血管生成素-2联合细胞外水在预测心脏手术后并发症方面有前景。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Patients undergoing cardiac surgery are prone to numerous complications. Increased vascular permeability may be associated with morbidity and mortality due to hemodynamic instability, fluid overload, and edema formation. We hypothesized that markers of endothelial injury and inflammation are associated with capillary leak, ultimately increasing the risk of postoperative complications.

METHODS: In this prospective, observational, multidisciplinary cohort study at our tertiary academic medical center, we recruited 405 cardiac surgery patients. Patients were assessed daily using body impedance electrical analysis, ultrasound, sublingual intravital microscopy, and analysis of serum biomarkers. Multivariable models, as well as machine learning, were used to study the association of angiopoietin-2 with extracellular water as well as common complications after cardiac surgery.

RESULTS: The majority of patients underwent coronary artery bypass grafting, valvular, or aortic surgeries. Across the groups, extracellular water increased postoperatively (20 ± 6 preoperatively to 29 ± 7L on postoperative day 2; P < 0.001). Concomitantly, the levels of the biomarker angiopoietin-2 rose, showing a strong correlation based on the time points of measurements (r = 0.959, P = 0.041). Inflammatory (IL-6, IL-8, CRP) and endothelial biomarkers (VE-Cadherin, syndecan-1, ICAM-1) suggestive of capillary leak were increased. After controlling for common risk factors of edema formation, we found that an increase of 1 ng/mL in angiopoietin-2 was associated with a 0.24L increase in extracellular water (P < 0.001). Angiopoietin-2 showed increased odds for the development of acute kidney injury (OR 1.095 [95% CI 1.032, 1.169]; P = 0.004) and was furthermore associated with delayed extubation, longer time in the ICU, and a higher chance of prolonged dependence on vasoactive medication. Machine learning predicted postoperative complications when capillary leak was added to standard risk factors.

CONCLUSIONS: Capillary leak and subsequent edema formation are relevant problems after cardiac surgery. Levels of angiopoietin-2 in combination with extracellular water show promising potential to predict postoperative complications after cardiac surgery.

TRIAL REGISTRATION NUMBER: German Clinical Trials Registry (DRKS No. 00017057), Date of registration 05/04/2019, www.drks.de.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Wollborn J, Zhang Z, Gaa J, et al. Angiopoietin-2 is associated with capillary leak and predicts complications after cardiac surgery. Ann Intensive Care. 2023. PMID: 37552379. doi:10.1186/s13613-023-01165-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。